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In Brief
Nautiyal et al. show that serotonin 1B
receptors modulate aggressive and
impulsive behavior through distinct
neural circuits. Adolescent expression of
forebrain heteroreceptors influences
aggressive behavior, while a separate
population affects impulsive behavior
during adulthood.
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Impulsive and aggressive behaviors are both modu-
lated by serotonergic signaling, specifically through
the serotonin 1B receptor (5-HT1BR). 5-HT1BR
knockout mice show increased aggression and
impulsivity, and 5-HT1BR polymorphisms are asso-
ciated with aggression and drug addiction in hu-
mans. To dissect the mechanisms by which the
5-HT1BR affects these phenotypes, we developed
a mouse model to spatially and temporally regulate
5-HT1BR expression. Our results demonstrate that
forebrain 5-HT1B heteroreceptors expressed during
an early postnatal period contribute to the develop-
ment of the neural systems underlying adult aggres-
sion. However, distinct heteroreceptors acting
during adulthood are involved in mediating impul-
sivity. Correlating with the impulsivity, dopamine
in the nucleus accumbens is elevated in the
absence of 5-HT1BRs and normalized following
adult rescue of the receptor. Overall, these data
show that while adolescent expression of 5-HT1BRs
influences aggressive behavior, a distinct set of
5-HT1B receptors modulates impulsive behavior
during adulthood.
INTRODUCTION
Impulsivity and aggression are related behavioral phenotypes
that are both modulated by serotonin (Coccaro, 1992).
Although highly comorbid, frequently affected by the same
manipulations, and often referred to as a single trait—impul-
sive-aggression (Balleine and Dickinson, 1998; Dalley et al.,
2002)—they are distinct behavioral constructs with potentially
discrete underlying neural systems (Garcı´a-Forero et al.,
2009). Little is known about how serotonin modulates the
underlying neural circuits or whether there is a develop-
mental contribution to these effects. Studies in humansand a variety of animal models suggest that increased seroto-
nergic signaling during development is associated with
increased aggressive and impulsive behavior (Cases et al.,
1995; Dennis et al., 2013; Ricci and Melloni, 2012). How-
ever, the reverse is true in adulthood—serotonin levels are
inversely correlated with aggression, impulsivity, and risky
behavior (Audero et al., 2013; Brown et al., 1979; Crockett
et al., 2009; Higley and Linnoila, 1997). These differential
effects may be mediated by distinct underlying neural circuits
and/or different sensitive periods. Since aggression and impul-
sivity are intermediate phenotypes in a number of mental
health disorders, including addictive disorders, antisocial per-
sonality disorder, and attention deficit disorder, understanding
the underlying neural circuit(s) may help develop more effec-
tive treatments.
The serotonin 1B receptor (5-HT1BR) is implicated in both
aggressive and impulsive behavior. In humans, polymor-
phisms in 5-HT1BR have been linked to impulsive aggression,
anger, conduct disorder, and other disorders that have
dysregulated impulse control such as substance use disorders
(Cao et al., 2013; Conner et al., 2010; Jensen et al., 2009;
Zouk et al., 2007). In mouse models, 5-HT1BR knockout
(KO) mice are highly aggressive and impulsive. Specifically,
conspecific male territorial aggression is increased—KO
residents attack intruders more often and with a shorter
latency (Saudou et al., 1994). KO mice also exhibit in-
creased cocaine self-administration and low response inhibi-
tion (Pattij et al., 2003; Rocha et al., 1998). While these
studies implicate 5-HT1BR in modulating adult aggressive
and impulsive behavior, they do not address the potential
developmental impact of 5-HT1BR, nor delineate the underly-
ing neural circuits.
The 5-HT1BR is a G protein coupled receptor (GPCR) that
inhibits neurotransmitter release from both serotonergic and
non-serotonergic neurons (reviewed in Sari, 2004). The ‘‘autor-
eceptor’’ population of 5-HT1BRs is located on the axon
terminals of serotonergic cells, thus affecting the release of
serotonin in many brain regions. The ‘‘heteroreceptor’’ popula-
tion of 5-HT1BRs is located on nerve terminals of neurons
from other neurotransmitter systems including glutamate,
GABA, dopamine, and acetylcholine (Boschert et al., 1994;Neuron 86, 813–826, May 6, 2015 ª2015 Elsevier Inc. 813
Figure 1. Characterization of the Tissue-Specific Regulation of 5-HT1BR Expression in the Floxed tetO1B Transgenic Mouse Model
Top: schematics of transgenic constructs used to manipulate 5-HT1B receptor expression are shown for single tetO1B+/+ transgenic (A), b-actin-tTS+::tetO1B+/+
(D), CaMKII-tTS+::tetO1B+/+ (G), and ePet-Cre+::tetO1B+/+ (J) mice. Cartoons of brains illustrate regions of 5-HT1BRmRNA, including cortex (ctx), dorsal striatum
(str), hippocampus (hpc), hypothalamus (hyp), thalamus (thal), substantia nigra (sn), raphe, and cerebellum (cb). Regions of mRNA knockdown are indicated for
each manipulation by a lack of shading. Middle: receptor autoradiographs show heat map distribution of 125I-cyanopindolol receptor binding in three repre-
sentative coronal sections throughout the brain, rostral at bregma +0.5 mm, mid at bregma 2.3 mm, caudal at bregma 3.5 mm for tetO1B+/+ (B), b-actin-
tTS+::tetO1B+/+ (E), and CaMKII-tTS+::tetO1B+/+ (H) mice. Color scheme from red to blue indicates highest to lowest binding. Representative photomicrographs
show DIG-labeled 5-HT1BR mRNA in the raphe and the dorsal striatum as a control region, for ePet-Cre and ePet-Cre+ mice (K). Bottom: quantification of
receptor binding and 5-HT1B mRNA expression for tetO1B+/+ (C), b-actin-tTS+::tetO1B+/+ (F), CaMKII-tTS+::tetO1B+/+ (I), and ePet-Cre+::tetO1B+/+ (L) mice are
represented as group means ± SEM. Left axis shows levels of receptor binding in cortex, dorsal striatum, nucleus accumbens, hypothalamus, and substantia
nigra. The number of 5-HT1BRmRNA+ cells in the raphe are shown for each transgenic mouse line and littermate controls on the right axis. Data are presented as
group means ± SEM, *p < 0.05.
See also Figure S1.Pazos et al., 1985). In all cases, the receptor is synthesized in
the cell body and transported to pre-synaptic terminals, where
it is coupled to either the G protein Gi or Go (Boschert et al.,
1994) and inhibits neurotransmitter release (Mizutani et al.,
2006).
To dissect the role of the 5-HT1BR in mediating aggressive
and impulsive behavior, we have generated a targeted trans-
genic mouse that permits temporal and spatial regulation of
5-HT1BR (Figure 1). A floxed tetracycline operator (tetO)-5-
HT1B cDNA cassette has been inserted in place of the
endogenous coding region of htr1b to generate Htr1btetO/tetO
mice (referred to as tetO1B). Crossing tetO1B mice to trans-
genic mice expressing either the tetracycline-dependent tran-
scriptional silencer (tTS) or Cre recombinase allows knock-
down of htr1b expression. Here we have used the814 Neuron 86, 813–826, May 6, 2015 ª2015 Elsevier Inc.ubiquitous b-actin promoter and two tissue-specific pro-
moters—CaMKIIa and Pet1—to drive 5-HT1BR knockdown
of all receptors, forebrain heteroreceptors, or autoreceptors,
respectively. Our data show that ubiquitous knockdown re-
sults in aggressive and impulsive behavior (in keeping with
the original knockout phenotype). However, rescue of receptor
expression in adulthood with doxycycline reverses the impul-
sive, but not the aggressive, phenotype. This suggests that
adult aggression can be determined early during develop-
ment, while impulsivity can be modulated throughout adult-
hood. Furthermore, CaMKIIa-mediated forebrain knockdown
results in aggressive, but not impulsive, behavior. Overall,
our data indicate that the 5-HT1BR mediates aggressive and
impulsive behavior through modulation of distinct circuits at
different times.
Figure 2. Characterization of the Temporal Regulation of 5-HT1BR Expression in the Floxed tetO1B Transgenic Mouse Model
Diagrams are shown for the approximate time course of receptor expression in the brain of b-actin-tTS+ mice following doxycycline treatment throughout life or
beginning in adulthood. Schematic charts showprotein levels of autoreceptors (red), heteroreceptors in CaMKII+ cells (green), and all other heteroreceptors (blue)
throughout development. Bars below chart depict the timing of doxycycline administration, with black indicating the presence of doxycycline andwhite indicating
its absence. The quantification of receptor binding (left) and the number of 5-HT1BR mRNA+ cells (right) are shown for b-actin-tTS+ mice and b-actin-tTS
controls following whole-life rescue (A), adult rescue (B), and adult knockdown (C). Data are presented as group means ± SEM.
See also Figures S2 and S3.RESULTS
Generation and Characterization of Tissue-Specific
and Conditional 5-HT1BR Transgenic Mouse
Insertion of the floxed tetO1B cassette (tet operator and htr1b
cDNA) in place of the endogenous htr1b gene did not alter base-
line expression of 5-HT1BR in the brain (Figures 1A–1C, S1A–
S1C, and S1E; F1,6 = 0.01, p > 0.05). Crossing tetO1B mice to
b-actin-tTS mice (henceforth referred to as b-actin-tTS mice)
(Mallo et al., 2003) yielded mice with ubiquitous knockdown of
5-HT1BR (Figure 1D). Throughout life, these mice had an
absence of all receptor binding throughout the brain (Figures
1E, 1F, S1D, and S1F; tTS versus tTS+: F1,6 = 58.92, p <
0.001; tTS+ versus zero: t83 = 0.66, p > 0.05). For tissue-specific
knockdown, tetO1B mice were crossed to CaMKIIa-tTS mice
(Richardson-Jones et al., 2011) to assess the contribution of het-
eroreceptors. CaMKIIa-tTS+::tetO1B+/+ (henceforth referred to
as CaMKII-tTS+) mice showed postnatal knockdown of the
expression of one subset of forebrain receptors in the striatum,
hippocampus, and cortex (Figure 1G). This resulted in a
decrease of 5-HT1BRbinding in the striatum, hippocampus, cor-
tex, substantia nigra, subthalamic nucleus, olfactory tubercle,
and globus pallidus by postnatal (PN)21 (Figures 1H, 1I, S1G,
S1H, and S3C; F1,6 > 10.90, p < 0.05). 5-HT1BR binding was un-
affected in other brain regions measured that represent the re-
maining population of 5-HT1B heteroreceptors (Figure S1G;F1,6 = 0.51, p > 0.05). These results demonstrate the ability to
spatially regulate 5-HT1BR expression in the tetO1B mice.
TetO1B mice were also crossed to mice expressing the ePet-
Cre transgene (Scott et al., 2005) (B6.Cg-Tg(Fev-cre)1Esd/J,
stock 012712; Jackson Laboratory). ePet-Cre::tetO1B+/+ mice
(henceforth referred to as ePet-Cre mice) had normal 5-HT1BR
expression in all brain regions as measured by receptor autora-
diography (F1,6 = 0.19, p > 0.05); however, any differences in re-
ceptor binding in ePet-Cre+ mice were likely obscured due to the
fact that autoreceptors are distributed widely at relatively low
density throughout brain regions that also contain high expres-
sion of heteroreceptors (Figure 1J). To determine the extent of
autoreceptor knockdown, 5-HT1BR mRNA was assessed in
the raphe. The number of 5-HT1BR mRNA positive cells was
reduced in the raphe (Figure 1K; F1,6 = 44.30, p < 0.001), but
not other brain regions (Figure 1L), of ePet-Cre+ mice. Because
some mRNA expression remained in the raphe, we confirmed
the functional effect of autoreceptor knockdown using serotonin
microdialysis (Figure S1I; t20 = 4.69, p < 0.001).
Receptor expression was also regulated temporally in b-actin-
tTS mice by administering doxycycline in the food. Whole-life
administration of doxycycline to b-actin-tTS+ mice resulted in
rescue of the receptor throughout the brain (Figures 2A, S2A,
and S2B; b-actin-tTS+ with doxycycline versus tTS with doxy-
cycline: F1,6 = 0.10, p > 0.05). Additionally, administration
of doxycycline beginning in adulthood rescued receptorNeuron 86, 813–826, May 6, 2015 ª2015 Elsevier Inc. 815
expression throughout the brain (Figures 2B, S2C, and S2D;
F1,9 = 0.61, p > 0.05). A time course analysis of the rescue of re-
ceptor expression revealed that expression returned to normal
levels by 21 days after beginning doxycycline administration
(Figure S3A). Adult knockdown was also possible in the b-actin
line through withdrawal of doxycycline at PN60. Although the
knockdown was not as complete as whole-life knockdown (re-
ceptor binding values were significantly different from 0 at
PN120, t83 = 6.78, p < 0.001), there was a significant reduction
compared to littermate tTS controls (Figures 2C, S2E, and
S2F; F1,6 = 68.63, p < 0.001).
Aggressive Behavior Is Mediated by Developmental
Expression of Forebrain 5-HT1B Heteroreceptors
b-actin-tTS+ mice that lacked all 5-HT1BR throughout life were
more aggressive compared to b-actin-tTS tetO1B littermates
(Figure 3A), which is consistent with the phenotype seen in
constitutive 5-HT1B KO mice (Saudou et al., 1994). All pairs of
b-actin-tTS+ mice (six out of six) displayed aggressive behavior,
while only one pair of tTS mice showed aggression (Figure 3B;
c21 = 8.57, p < 0.01). b-actin-tTS
+ duration of aggression was
also increased—on average displaying aggressive behaviors
including mounting, tail rattling, and/or biting attacks for over a
minute out of the 5-min session (Figure 3C; F1,10 = 25.13, p <
0.05). Compared to controls, the number of attacks was also
increased in b-actin-tTS+ mice (Figure S4A; F1,10 = 8.31, p <
0.05). Their latency to attack was also significantly lower (Fig-
ure S4B; c21 = 10.0, p < 0.005), but there was no significant dif-
ference in the duration of non-aggressive social behavior
compared to controls (Figure S4G; F1,10 = 2.04, p > 0.05).
Whole-life rescue of 5-HT1BR expression in b-actin-tTS+ mice
(dox all life) rescued behavior to control levels of aggression.
Specifically, only one out of nine b-actin-tTS+ pairs on doxycy-
cline showed aggressive behavior, which was not significantly
different compared to their b-actin-tTS littermates (Figure 3B;
c21 = 0.01, p > 0.05).
Interestingly, adult rescue of 5-HT1BR in b-actin-tTS+ mice
did not rescue normal behavior. Following doxycycline treat-
ment beginning at PN60, all eight of eight b-actin-tTS+ pairs
were aggressive, significantly more than b-actin-tTS pairs (Fig-
ure 3B; c21 = 10.37, p < 0.01). b-actin-tTS
+ pairs showed an
average of over a minute of aggressive behavior during the
5 min test, significantly more than b-actin-tTS pairs (F1,12 =
16.76, p < 0.05). This duration of aggression in b-actin-tTS+
mice treated in adulthood with doxycycline was comparable to
that seen in b-actin-tTS+ mice in the absence of the receptor
throughout life, suggesting no amelioration of the behavioral
phenotype with adult rescue of the receptor. b-actin-tTS+ mice
with adult rescue of the receptor also had an increased number
of attacks and decreased latency to attack compared to b-actin-
tTS mice, but the duration of non-aggressive social behavior
was unchanged (Figure S4G; F1,12 = 5.78, p < 0.05; c
2
1 = 8.89,
p < 0.005; F1,12 = 0.19, p > 0.05, respectively). Additionally, to
ensure that aggression did not result from knocking down
5HT1BR for an extensive period of time (i.e., 60 days) regardless
of the developmental stage, aggression was measured following
adult knockdown of 5-HT1BR by removal of doxycycline at
PN60. Pairs of b-actin-tTS+ mice were not significantly more816 Neuron 86, 813–826, May 6, 2015 ª2015 Elsevier Inc.aggressive than tTS control pairs (Figure 3B; c21 = 0.42, p >
0.05). These data suggest that developmental expression of
5-HT1BR is important for the regulation of adult aggressive
behavior.
The inability to rescue the normal phenotype with adult rescue
of the receptor was noteworthy, given pharmacology studies
that show that activation of 5-HT1BRs with agonists (e.g., ‘‘se-
renics’’) reduce adult aggressive behavior in mice (Fish et al.,
1999). To address this, CP-94,253, a 5-HT1BR-specific agonist,
was injected intraperitoneally (i.p.) into b-actin-tTS+ mice with
adult rescue of the receptor. CP-94,253 injection reduced
aggression in mice with adult rescue of the receptor, compared
to vehicle injection, in number of pairs attacking (Figure S4H;
c21 = 9.60, p < 0.01) and number of attacks (Figure S4I; F1,14 =
16.9, p < 0.01). There was no significant reduction in aggression
in CP-94,253-treated b-actin-tTS+ mice without rescue of
5-HT1BR expression (F1,14 = 0.121, p > 0.05), suggesting that
the effect of CP-94,253 on aggression was specific to
5-HT1BRs. These data demonstrate that the adult-rescued
5-HT1BRs are functional and also highlight that there are distinct
adult and developmental effects of 5-HT1BR on mouse
aggression.
Early postnatal rescue of 5-HT1BR expression was able to
reverse the aggressive phenotype in b-actin-tTS+ mice. Admin-
istration of doxycycline beginning at PN0, but not at PN7, pre-
vented the development of adult aggression (Figure 3B). Specif-
ically, following administration of doxycycline beginning at PN0,
there was no significant difference between genotypes in the
percent of pairs showing aggression (c21 = 0.41, p > 0.05) nor
in the time spent engaging in aggressive behaviors (Figure 3C;
F1,8 = 3.23, p > 0.05). Conversely, when doxycycline administra-
tion began at PN7, b-actin-tTS+ mice showed elevated aggres-
sion compared to b-actin-tTS controls (Figure 3B; c21 = 6.20,
p < 0.05 for PN7). Since rescue of receptor expression led to
normal expression levels by 21 days after the start of doxycycline
administration (Figure S3C), these data suggest a sensitive
period of approximately PN21–PN28 for the development of
aggressive behavior.
Further localizing the 5-HT1BR subpopulation(s) subserving
aggressive behavior, we found that knockdown of postnatal
forebrain heteroreceptors using CaMKII-tTS+ mice resulted in
increased aggressive behavior. Specifically, more CaMKII-tTS+
pairs were aggressive compared to CaMKII-tTS pairs (Fig-
ure 3D; 11 of 14 for tTS+ versus 3 of 11 for tTS; c21 = 6.58,
p < 0.05). Additionally, CaMKII-tTS+ mice spent more time on
average engaging in aggressive behavior—consisting mostly of
tail rattling and biting attacks (Figures 3E and S4C; F1,23 =
7.60, p < 0.05)—and also had a shorter latency to attack (Fig-
ure S4D; c21 = 13.44, p < 0.001). Whole-life treatment with doxy-
cycline reduced the aggression in CaMKII-tTS+ mice to control
levels (Figure 3D;c21 = 0.42, p > 0.05) and lengthened the latency
to attack (Figure S4D; c21 = 0.25, p > 0.05). The time course of
the CaMKII-tTS-mediated knockdown (see Figure S3C) was
consistent with the sensitive period suggested from the
b-actin-tTS studies above. Specifically, the majority of forebrain
heteroreceptor knockdown in CaMKII-tTS+ mice was achieved
by PN21, with the full extent of knockdown by PN28. Taken
together, these data suggest that expression of forebrain
Figure 3. Developmental Expression of 5-HT1B Heteroreceptors Contributes to Aggressive Behavior in Adult Male Mice
(A) Schematic of experimental paradigm used for isolation-induced aggression assay that includes co-housing with females for the first week and three sub-
sequent interactions. Data from first interaction (shaded gray) is not included in analysis to allow for stabilization of aggressive behavior.
(B) The percentage of pairs of mice showing aggressive behavior is shown for b-actin-tTS control mice (black) and littermate b-actin-tTS+ mice (yellow) in six
experimental conditions: no doxycycline all life (whole-life knockdown), all-life doxycycline treatment (whole-life rescue), doxycycline treatment beginning at
PN60 (adult rescue), doxycycline administrations ending at PN60 (adult knockdown) and doxycycline treatment beginning at PN7 or PN0 (rescue at PN7 or PN0).
(C) Duration of aggressive behavior is shown, divided by type of behavior including biting, tail rattling, and mounting, for b-actin-tTS control mice (shades of
black) and b-actin-tTS+ (shades of yellow), presented as group means ± SEM.
(D and F) Percentage of pairs of CaMKII-tTS+ (green) or ePet-Cre+ (red) mice showing aggressive behavior compared to pairs of littermate controls (black).
(E and G) Duration of aggressive behavior is shown for CaMKII-tTS+ (shades of green), ePet-Cre+ (shades of red), and control mice (shades of black). Data are
presented as group means ± SEM, *p < 0.05.
See also Figure S4.heteroreceptors during the pubertal period is important for the
development of male aggression.
5-HT1B autoreceptor knockdown in ePet-Cre+ mice did not
significantly affect aggressive behavior. While baseline aggres-
sion was higher in this strain resulting in five out of eight pairs
showing aggressive behavior in the control ePet-Cre mice,
they were not significantly different from ePet-Cre+ mice (Fig-ure 3F; c21 = 0.58, p > 0.05). There were also no significant differ-
ences between control ePet-Cre+::tetO1B/mice compared to
ePet-Cre::tetO1B/ littermates (Figure 3F; c21 = 0.25, p >
0.05), ruling out effects of the transgene insertion on aggression
in this paradigm. Additionally, there were no significant differ-
ences in the time spent engaging in aggressive behaviors (Fig-
ure 3G; F1,13 = 0.45, p > 0.05), number of attacks (Figure S4E;Neuron 86, 813–826, May 6, 2015 ª2015 Elsevier Inc. 817
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Figure 4. Adult Expression of 5-HT1BR
Mediates Impulsive Behavior in the DRL
Paradigm
(A) Schematic describing the DRL operant para-
digm.
(B and D) The distribution of the latencies of lever
presses in the DRL is shown for b-actin-tTS+ mice
(yellow) and their littermate b-actin-tTS controls
(black) for whole-life knockdown (B) and adult
rescue (D) groups. Group means ± SEM are pre-
sented for latencies binned in 3 s intervals. The
dotted line represents the minimum response la-
tency (36 s) that is rewarded.
(C and E) The average ratio of the number of lever
presses to the number of rewards earned ± SEM is
shown for whole-life knockdown (C) and adult
rescue (E) groups. *p < 0.05.
See also Figure S5.F1,13 = 1.88, p > 0.05), or latency to attack (Figure S4F; c
2
1 = 1.79,
p > 0.05).
Impulsive Behavior in the DRL Is Mediated by Adult
Expression of 5-HT1BRs
Two operant behavior paradigms were used to measure two as-
pects of impulsivity. The first, a differential reinforcement of low-
rate responding (DRL) paradigm, reinforced the ability of a
mouse to refrain from responding for a set time period. For
example, in a DRL-36 paradigm, mice only receive a reward
following a lever press if the lever press was preceded by 36 s818 Neuron 86, 813–826, May 6, 2015 ª2015 Elsevier Inc.of no lever pressing (Figure 4A). Whole-
brain knockout of the 5-HT1BR in
b-actin-tTS+ mice resulted in deficits in
the DRL task, indicating a more impulsive
phenotype, as seen in the constitutive
5-HT1BR knockout (Pattij et al., 2003).
Compared to littermate b-actin-tTS con-
trols, b-actin-tTS+ mice had 80% more
burst responses, which are responses
with a latency of <3 s (Figure 4B; F1,28 =
7.2, p < 0.05). The latencies of the remain-
ing non-burst responses represented a
unimodal distribution that was signifi-
cantly different between genotypes (Fig-
ure 4B; F1,28 = 23.63, p < 0.05). The distri-
bution was left-shifted in b-actin-tTS+
mice, indicating increased premature re-
sponding (genotype 3 latency interac-
tion: F18,504 = 11.79, p < 0.05). Cumulative
distribution functions of individual animals
revealed that the majority of responses
from b-actin-tTS+ mice were made earlier
than those of their littermate tTS controls
(Figure S5C). This resulted in an increased
number of non-rewarded lever presses
and therefore a significantly higher
response-to-reward ratio in b-actin-tTS+
mice (Figure 4C; F1,28 = 11.89, p < 0.05).Finally, a Gaussian function was fitted to the non-burst response
distribution and revealed a significantly earlier peak responding
latency in b-actin-tTS+ mice compared to b-actin-tTS controls,
whose peak responding was nearly 10 s later (Figure S5D; F1,28 =
23.04, p < 0.05). The poor performance of the b-actin-tTS+ mice
in the DRL paradigmwas not likely due to a lack of learning, since
the peak of the response distribution increased as the target wait
time was increased during training (Figure S5B). In fact, the num-
ber of sessions required tomeet criterion in lever pressing acqui-
sition was lower in b-actin-tTS+ mice, suggesting no deficit in
overall operant learning (F1,28 = 4.91, p < 0.05). Additionally,
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Figure 5. Neither CaMKII-tTS+ nor ePet-
Cre+ Mice Show Impulsive Behavior in the
DRL Paradigm
(A and C) The distribution of the latencies of lever
presses in the DRL is shown for CaMKII-tTS+ mice
(green), ePet-Cre+ mice (red) and their respective
littermate controls (black). Group means ± SEM
are presented for latencies binned in 3 s intervals.
The dotted line represents the minimum response
latency (36 s) that is rewarded.
(B and D) The average ratio of the number of lever
presses to the number of rewards earned ± SEM is
shown for each group.
See also Figure S6.there were no significant differences in the number of head en-
tries into the reward receptacle (Figure S5E; F1,28 = 1.81, p >
0.05). A control experiment ruled out an effect of the tTS trans-
gene insertion on DRL behavior, as the behavior of b-actin-
tTS+mice treatedwith doxycycline throughout life was not signif-
icantly different from that of littermate control b-actin-tTSmice
(Figures S5K–S5P). Overall, these data confirmed a role for
5-HT1BRs in regulating impulsivity.
Interestingly and unexpectedly, the impulsive phenotype was
fully recovered with adult rescue of 5-HT1BR, differentiating it
from the aggressive phenotype. Doxycycline treatment begin-
ning in adulthood (PN60) resulted in no significant genotype
differences between b-actin-tTS and b-actin-tTS+ mice in
any parameter analyzed from the DRL paradigm (Figures S5F–
S5J). Specifically, burst and non-burst responding in
b-actin-tTS+ mice were normalized to control levels (Figure 4D;Neuron 86, 813F1,26 = 0.61, p > 0.05), and the distribution
of non-burst responses was not signifi-
cantly different from b-actin-tTS con-
trols (F1,26 = 0.01, p > 0.05). The cumula-
tive distribution functions of individual
animals were overlapping (Figure S5H),
and there were no significant differences
between genotypes in the ratio of lever
presses to rewards earned (Figure 4E;
F1,26 = 0.05, p > 0.05). The means of the
fitted curves were not significantly dif-
ferent for b-actin-tTS and b-actin-tTS+
mice treated with doxycycline (Figure S5I;
F1,26 = 0.02, p > 0.05). Taken together with
the data from the aggression assays,
adult rescue of 5-HT1BRs resulted in
aggressive, but not impulsive mice. This
dissociates the impulsive phenotype
from that of aggression and suggests
different sensitive periods of serotonergic
modulation.
The contribution of 5-HT1B autorecep-
tors and forebrain heteroreceptors to the
impulsive phenotype was also assessed
in the DRL operant paradigm. Neither
CaMKII-tTS+ nor ePet-Cre+ mice were
more impulsive than their littermate con-trols (Figures 5 and S6A–S6J). There were no significant geno-
type differences in the number of burst lever presses (Figure 5A,
F1,11 = 1.82, p > 0.05 for CaMKII-tTS; Figure 5C, F1,16 = 0.93, p >
0.05 for ePet-Cre), or in the distribution of lever press latencies
(F1,11 = 2.48, p > 0.05 for CaMKII-tTS; F1,16 = 0.34, p > 0.05 for
ePet-Cre). The cumulative distribution functions of individual
animals showed largely overlapping response curves for both
CaMKII-tTS+ and ePet-Cre+ mice compared to their littermate
controls (Figures S6C and S6H). Lastly, there were no significant
differences in the ratio of lever presses to rewards earned (Fig-
ure 5B, F1,11 = 3.21, p > 0.05 for CaMKII-tTS; Figure 5D, F1,16 =
0.06, p > 0.05 for ePet-Cre), nor in the means of the curves fitted
to lever press responsedistributions (FiguresS6DandS6I; F1,11 =
2.18, p > 0.05 for CaMKII-tTS; F1,16 = 0.10, p > 0.05 for ePet-Cre).
Control experiments comparing ePet-Cre+::tetO1B/ mice to
ePet-Cre::tetO1B/ mice, and CaMKII-tTS+ mice treated–826, May 6, 2015 ª2015 Elsevier Inc. 819
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Figure 6. Adult Expression of 5-HT1BR Mediates Impulsive Behavior in a Go/No-Go Task
(A) Schematic illustrating the house-light and lever-light cues in the operant box during the inter-trial interval (ITI) and during Go and No-Go trials.
(B and C) The group means ± SEM of the impulsivity index, defined as the number of rewarded No-Go trials subtracted from the number of rewarded Go trials, is
shown over 15 days for b-actin-tTS (black) and tTS+ (yellow) mice in the absence of doxycycline (B) or following adult administration (C). No-Go trials lasted for
5 s on the first 12 days, and 10 s on days 13–15. *p < 0.05.
See also Figure S7.with doxycycline throughout life to CaMKII-tTS mice treated
with doxycycline throughout life, showed no significant effects
of insertion of either transgene on behavior in the DRL (Figures
S6K–S6V). Compared to the results from the aggression studies,
the data again suggest a dissociation of aggressive and impul-
sive behaviors, with forebrain heteroreceptor knockdown result-
ing in increased aggression, but not impulsivity.
Impulsive Behavior in the Go/No-Go Task IsMediated by
Adult Expression of 5-HT1BRs
To extend the behavioral differences seen in theDRLparadigm, a
second operant behavioral taskmeasuring impulsivity was used.
A mouse model of the Go/No-Go paradigm adapted from previ-
ous studies (McDonald et al., 1998) rewarded the ability to refrain
from responding during specific trials. Mice were presented with
‘‘Go’’ trials, in which lever presses were rewarded, and ‘‘No-Go’’
trials, in which an absence of lever pressing was rewarded (Fig-
ure 6A). b-actin-tTS+ mice were more impulsive than b-actin-
tTS littermate controls, and the behavioral deficit was amelio-
rated with doxycycline treatment in adulthood. Specifically, in
the absence of doxycycline, b-actin-tTS+mice were more impul-
sive across all trials compared to b-actin-tTS controls as in-
dexed by the number of correct No-Go trials subtracted from
the number of correct Go trials (Figure 6B; F1,27 = 14.29, p <
0.001). Broken down by trial type, b-actin-tTS+ mice earned
more rewards during Go trials (Figure S7A; F1,27 = 7.75, p <
0.01) and fewer rewards during No-Go trials (Figure S7B;
F1,27 = 11.63, p < 0.005) compared to b-actin-tTS
 mice. Over820 Neuron 86, 813–826, May 6, 2015 ª2015 Elsevier Inc.the 12 sessions, while both genotypes decreased their impul-
sivity index, the decrease was greater in b-actin-tTS mice
(genotype3 session interaction: F11,297 = 3.03, p < 0.001). During
the 12th session, b-actin-tTS+ mice had significantly more false
alarms (unrewarded No-Go trials), averaging over 60%,
compared to b-actin-tTS mice, who had a 36% false alarm
rate (F1,27 = 5.58, p < 0.05). Increasing the duration of the No-
Go trials from5 s to 10 s resulted in decreases in the performance
of both genotypes, as measured by impulsivity index. However,
b-actin-tTSmice were able to recover their performance within
3 days, while b-actin-tTS+ mice were not (Figure 6B; F2,54 = 4.65,
p < 0.05). These deficits in the performance of b-actin-tTS+ mice
in the Go/No-Go task suggested an impulsive phenotype,
consistent with results from the DRL paradigm.
To confirm that the poor performance seen in the b-actin-tTS+
mice in the Go/No-Go task was due to an impulsive phenotype
rather than a deficit in the ability to learn the trial cues, a control
experiment assessed cue-based learning. In this task, the cues
that signaled Go and No-Go trials were used to signal left-lever
or right-lever trials, and as such, all trials required a response
(Figure S7C). The number of correct trials, represented by the
number of rewards earned, was not different between genotypes
(Figure S7D; F1,27 = 2.27, p > 0.05). This suggests that the
inability to withhold responses during No-Go trials was not due
to a deficit in cue-learning.
Rescue of 5-HT1BR expression in adulthood with administra-
tion of doxycycline resulted in no significant differences in per-
formance in the Go/No-Go task between b-actin-tTS+ mice
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Figure 7. Adult Expression of 5-HT1BR Me-
diates Dopamine Levels in the Nucleus Ac-
cumbens
Dopamine levels in microdialysis samples from the
nucleus accumbens (A) and dorsal striatum (B) are
shown as group means ± SEM of the percent of
baseline for 100 min following peripheral injection
of the dopamine transporter inhibitor GBR 12090.
Insets show area under the curve (AUC) of the
dopamine levels (% baseline) over the 100 min
following injection of GBR 12090. *p < 0.05; **p <
0.01.
See also Figure S8.and b-actin-tTS controls. Specifically, there were no significant
differences in impulsivity index (Figure 6C; F1,27 = 0.10, p > 0.05),
number of correct Go trials (F1,27 = 0.01, p > 0.05), or number of
correct No-Go trials (F1,27 = 0.30, p > 0.05). The number of false
alarms on day 12 was also not significantly different between ge-
notypes (F1,27 = 0.01, p > 0.05). These results were consistent
with performance seen in the DRL, suggesting that adult expres-
sion of 5-HT1BRs modulates impulsivity as measured in two op-
erant assays of behavioral inhibition.
Adult 5-HT1BRs Regulate Dopamine Levels in the
Nucleus Accumbens
Given the importance of dopamine in modulating impulsive
behavior (Cole and Robbins, 1989; Pattij et al., 2007), we
measured dopamine (DA) levels in our knockdown mice. To
determine the effects of 5-HT1BR expression on CNS DA levels,
microdialysis was performed in the nucleus accumbens (NAc)
and dorsal striatum following peripheral injection of GBR
12090, a DA transporter (DAT) blocker (Figures S8C and S8D).
There was a main effect of 5-HT1BR expression on DA levels in
the NAc (Figure 7A; F3,32 = 5.18, p < 0.01). b-actin-tTS
+ mice
had significantly greater increases in DA levels in the NAc
compared to b-actin-tTSmice (F1,20 = 9.71, p < 0.01). Interest-
ingly, adult rescue of the 5-HT1BR normalized DA levels in the
NAcofb-actin-tTS+mice. Specifically, adult treatmentwith doxy-
cycline in b-actin-tTS+ mice resulted in significantly smaller GBR
12090-induced DA increases compared to b-actin-tTS+ mice
without doxycycline (F1,13 = 7.05, p < 0.05); the DA increases in
b-actin-tTS+ mice were not significantly different from those of
b-actin-tTS mice or b-actin-tTS+ mice given doxycycline
throughout life (F1,21 = 0.55, p > 0.05 and F1,12 = 0.06, p > 0.05,
respectively). These results suggest that adult expression of
5-HT1BR regulates NAcDA levels. In contrast, there were no sig-
nificant effects of 5-HT1BR expression on levels of DA in the dor-
sal striatum, as previously reported (Shippenberg et al., 2000)
(Figure 7B; F3,32 = 1.53, p > 0.05). There were also no group dif-
ferences in the baseline levels of DA in the NAc or dorsal striatum
(Figure S8A, NAc: F3,32 = 1.60,p > 0.05; Figure S8B, dorsal stria-
tum: F3,32 = 1.66, p > 0.05). These data indicate that 5-HT1BRs
regulate DA release in the NAc during adulthood, which may be
a mechanism by which 5-HT1BRs affect impulsivity.DISCUSSION
The development of a tissue-specific and temporally conditional
5-HT1BR mouse model allowed us to investigate the contribu-
tion of serotonin signaling to the neural circuits underlying
aggression and impulsivity (Figure 8). First, we showed that
aggressive behavior is mediated by the developmental expres-
sion of 5-HT1B heteroreceptors. Specifically, whole-life,
whole-brain knockdown of 5-HT1BRs resulted in increased
aggressive behavior, in agreement with our previous results us-
ing constitutive knockouts (Saudou et al., 1994). Consistent with
the presence of a developmental sensitive period, rescue of
5-HT1BR expression in early post-natal development, but not
in adulthood, ameliorated the aggressive behavior. Furthermore,
forebrain heteroreceptors located on CaMKII-expressing cells
mediated this aggressive phenotype, while a reduction in autor-
eceptors did not modulate aggression. In contrast, the data
show a different pattern for themodulation of impulsive behavior.
Using two operant conditioning paradigms (DRL and Go/No-
Go), mice that lacked all 5-HT1BRs were unable to withhold
lever pressing responses, suggesting heightened impulsivity.
Interestingly, this impulsive phenotype was fully reversed by
rescue of receptor expression in adulthood. Similar to aggres-
sion, knockdown of 5-HT1B autoreceptors did not affect
impulsive behavior. However, unlike in aggression, forebrain
5-HT1BRs located in CaMKII-expressing cells did not mediate
impulsive behavior. Since CaMKII-tTS+ cells represent only a
subset of 5-HT1B heteroreceptor-containing neurons, these
data suggest that a different set of 5-HT1B receptors, located
on either non-CaMKII+ neurons, neurons in regions not knocked
down by our CaMKII-tTS line (e.g., lateral septum, hypothala-
mus, VTA), or even non-neuronal cells are involved in modulating
impulsivity compared to aggressive behavior. Overall, the data
presented here support the claim that serotonin can affect
aggression and impulsivity through distinct circuits and during
different time periods by acting through 5-HT1BRs.
We have discovered a developmental sensitive period during
which serotonin affects later-life adult aggressive behavior.
Many studies in both humans and animal models now support
the idea that there are specific periods of development during
which genetic and environmental perturbations can influenceNeuron 86, 813–826, May 6, 2015 ª2015 Elsevier Inc. 821
Figure 8. Summary of Spatial and Temporal Contributions of 5-HT1BR to Aggression, Impulsivity, and Dopamine Levelsadult phenotypes related to psychiatric disorders, including anx-
iety, depression, aggression, and antisocial personality disorder
(Ansorge et al., 2004; Caspi et al., 2002, 2003; Dodge et al., 1990;
Richardson-Jones et al., 2011). Aggressive behavior has been
linked to developmental alterations in monoamine levels through
disruptions in monoamine oxidase A (MAOA) activity. A genetic
null mutation in the gene encoding MAOA results in increased
aggressive and antisocial behavior (Brunner et al., 1993). A
less severe reduction in MAOA activity caused by a variable
number tandem repeat polymorphism in the MAOA promoter is
associated with conduct disorder and antisocial behavior when
coupled with childhood maltreatment (Caspi et al., 2002). Lastly,
an MAOA KO mouse model displays increased aggressive
behavior, which correlates with altered developmental levels of
serotonin and norepinephrine (Cases et al., 1995). Other recent
studies have implicated dopaminergic signaling during develop-
ment in the generation of aggressive behavior in rodents. Specif-
ically, blockade of dopamine reuptake in mice during a post-
natal period (PN22–PN41) resulted in increased adult aggression
(Yu et al., 2014). Furthermore, aggression in hamsters induced
by adolescent administration of cocaine was ameliorated by
co-administration of paliperidone, a D2/5-HT2A receptor antag-
onist (Schwartzer et al., 2009). This study implicates the middle
of adolescence as the sensitive period for dopaminergic and
serotonergic effects on aggression. The sensitive periods re-
ported in these studies are consistent with the sensitive period
that we approximate from our data. Both the time course of
the doxycycline studies in b-actin mice (taking into account the
21-day lag in complete rescue of receptor expression; see Fig-
ure S3A) and the developmental time course of CaMKII promoter
activity (see Figure S3C), suggest that the period encompassing
postnatal days PN21–PN28 is important for the maturation of
neural circuits underlying adult aggressive behavior. However,
given the slow kinetics of the doxycycline effect on receptor
expression, other tools will be required to accurately define
this sensitive period further. This proposed sensitive period cor-
responds with the onset of adolescence, which is also the onset822 Neuron 86, 813–826, May 6, 2015 ª2015 Elsevier Inc.of play behavior, the development of social hierarchies, and the
appearance of aggressive behavior (Bartolomucci et al., 2004;
Pellis and Pasztor, 1999; Terranova et al., 1998).
The developmental, rather than adult, mechanism of action of
5-HT1BRs on aggression shown here, is dissociated from phar-
macological data showing that activation of 5-HT1BRs with ag-
onists such as the serenics reduces aggressive behavior when
administered in adulthood (Mos et al., 1992; Sijbesma et al.,
1991). The disconnect between knockout and pharmacological
phenotypes has been previously identified with regards to
5-HT1BR signaling (Castanon et al., 2000), but the lack of condi-
tional knockouts prevented investigation into compensatory
and/or developmental contributions to these effects. Here, we
show a developmental contribution of the receptor to adult
aggressive behavior, which seems to be distinct from the
5-HT1BR-mediated pharmacological effects on adult aggres-
sion. This dissociation is suggested by the fact that aggression
in the adult rescue mice could still be attenuated with acute
administration of a 5-HT1BR agonist. One possible explanation
is that there could be two populations of 5-HT1BRs that modu-
late aggression circuits at different developmental time points.
Also, although we show here that knocking out 5-HT1BRs in
CaMKII+ cells is sufficient to generate an aggressive phenotype,
it is still possible that other 5-HT1BRs are involved. Specifically,
5-HT1BRs are located in a number of other brain regions impli-
cated in aggression including the periaqueductal gray, ventro-
medial hypothalamus, and lateral septum (Lin et al., 2011; Siegel
et al., 1999; Simon et al., 1998). Adult expression of one of these
populations of receptors may also modulate aggressive
behavior. Another possibility is that serenics are affecting
aggression in adulthood indirectly through another mechanism,
such as reducing impulsivity. Finally, our data do not rule out
the possibility that 5-HT1BRs affect different facets of aggres-
sive behavior at different time points. Specifically, our paired
aggression assay could be measuring aggression-eliciting fac-
tors, rather than or in addition to offensive aggressive behavior
directly.
Unlike aggressive behavior, impulsive behavior is mediated by
the expression of 5-HT1BRs during adulthood. This was not pre-
dicted given the impulsive aggression seen in the 5-HT1BR KOs
and the frequent co-occurrence of these behavioral phenotypes.
Specifically, using the DRL and Go/No-go paradigms, we
measured impulsive action, a concept that includes behavioral
inhibition and is characterized by the inability to inhibit a
response. This type of impulsivity may be dissociated from
impulsive choice, which represents intolerance to delays and is
frequently measured in delayed discounting tasks (Bari and Rob-
bins, 2013; Broos et al., 2012). Evidence suggests that
5-HT1BRs affect impulsive action (Pattij et al., 2003), but may
not affect impulsive choice (Brunner and Hen, 1997). This is
important because these two aspects of impulsivity are thought
to be mediated by distinct circuits and may contribute to
different psychiatric disorders (Dalley et al., 2011; Robbins
et al., 2012). For example, deficits in impulsive action predict
substance abuse potential and severity of pathological gambling
(Brevers et al., 2012; Loos et al., 2009), while deficits in impulsive
choicemay play a larger role in attention deficit hyperactivity dis-
order (ADHD) (Solanto et al., 2001; Sonuga-Barke, 2003). Inter-
estingly, studies have implicated 5-HT1BR expression levels
and polymorphisms in substance use disorders and pathological
gambling (Cao et al., 2013; Potenza et al., 2013; Proudnikov
et al., 2006; Rocha et al., 1998). Our findings suggest that
different pharmacological approaches may be necessary de-
pending on the type of inhibitory control or impulsivity (or impul-
sivities) associated with each disorder.
The relationship between serotonin signaling and impulsive
behavior is complex. On one hand, studies show that impulsive
behavior is negatively correlated with serotonin levels (Fairbanks
et al., 2001; Harrison et al., 1997), and activation of serotonin
neurons or serotonin receptors reduces impulsivity (Evenden,
1999; Miyazaki et al., 2014). However, other evidence suggests
that increased serotonin levels in the prefrontal cortex are asso-
ciated with increases in impulsivity (Dalley et al., 2002), suggest-
ing potential brain region-specific effects. Additionally, activa-
tion of different serotonin receptors can have opposing effects
on impulsive behavior (Winstanley et al., 2004). Finally, recent
evidence suggests that dorsal raphe serotonin neurons also
release glutamate that can have behavioral effects similar to
that of serotonin (Liu et al., 2014). Although 5-HT1BR knockouts
have increased serotonin levels (Gardier et al., 2003; Malagie´
et al., 2001), it remains unclear whether this change in serotonin
signaling plays a role in modulating impulsivity. Here, we show
that knocking down 5-HT1B autoreceptors is not sufficient to
change impulsive behavior; however, our significant but incom-
plete knockdown still leaves open the possibility for the remain-
ing autoreceptors to be involved in the behavioral effects of
5-HT1BR knockout. Another possibility is that changes in seroto-
nergic tone via 5-HT1B autoreceptors contribute to increased
impulsivity only in conjunction with the absence of certain
5-HT1BR heteroreceptors. In such a situation, knockdown of
both autoreceptors and another population of 5-HT1B heterore-
ceptors would be necessary to elicit increased impulsive
behavior. One potential scenario leading to impulsivity could
therefore be an interaction of increased serotonergic tone
coupled with increased dopamine levels, as is supported bythe fact that depletion of serotonin with 5,7-dihydroxytryptamine
results in an attenuation of amphetamine-induced premature re-
sponding (Harrison et al., 1997). Similarly, serotonin signaling
could interact with dopamine to affect impulsivity.
Consistent with our results, there is evidence to support a role
for NAc DA levels in the regulation of impulsive action. Local in-
jection of amphetamine into the NAc increases premature re-
sponding, suggesting a lack of behavioral inhibition or increased
impulsive action (Cole and Robbins, 1987). These effects could
be blocked by a D2 receptor antagonist and were not affected
by lesions of the norepinephrine system, suggesting a dopami-
nergic action of amphetamine on impulsivity (Pattij et al.,
2007). Although 5-HT1BRsmay affect impulsive action via dopa-
mine in the NAc, there are many other potential mechanisms for
these effects. Dopamine signaling in a number of brain regions,
not limited to the NAc, has been linked to impulsivity and could
be involved in 5-HT1BR modulation of impulsive action. For
example, levels of dopamine and dopamine receptors in the
PFC are correlated with increased impulsive action (Bari and
Robbins, 2013; Counotte et al., 2009; Moon et al., 2014). Addi-
tionally, other neurotransmitters and neuromodulators play an
important role in modulating impulsive action. For example,
increasing norepinephrine levels results in increased impulsivity
(Swann et al., 2005, 2013) and increased levels of both vaso-
pressin and neuropeptide Y are associated with increased
impulsive behavior (Aliczki et al., 2014; Coccaro et al., 2012).
Furthermore, even decreased GABA synthesis in the NAc core
is sufficient to cause increases in impulsive action (Caprioli
et al., 2014).
Overall, this mouse model of 5-HT1BR-associated deficits in
impulse control provides a useful tool for the discovery of new
treatments for psychiatric disorders in which impulsivity is a
key phenotype. There is a substantial amount of evidence linking
5-HT1BR to impulsivity in humans, and our findings suggest that
pharmacologic interventions targeting 5-HT1BR-mediated
impulsivity may be effective in adults. Recent haplotype and
meta-analyses have confirmed links between 5-HT1BR poly-
morphisms and heroin, cocaine, and alcohol abuse (Cao et al.,
2013; Proudnikov et al., 2006). Additionally, increased
5-HT1BR binding is correlated with severity of gambling in path-
ological gamblers (Potenza et al., 2013). Last, a number of
studies including a meta-analysis have found significant associ-
ations between 5-HT1BRpolymorphisms andADHD in a number
of different populations (Banerjee et al., 2012; Gizer et al., 2009).
Future research will be aimed at investigating the circuits under-
lying these effects of 5-HT1BR on impulsivity and will hopefully
set the stage for pharmacological interventions aimed at
decreasing impulsive behavior in disorders such as substance
abuse, pathological gambling, and ADHD.
EXPERIMENTAL PROCEDURES
Please see Supplemental Experimental Procedures for full details of methods
and reagents.
Mice
A vector containing a floxed-tetO-htr1b cDNA-PGK-neo cassette was
introduced into the genome through homologous recombination in place of
the endogenous htr1b gene coding region (Figure S1). Spatial- andNeuron 86, 813–826, May 6, 2015 ª2015 Elsevier Inc. 823
temporal-specific knockdown was achieved through genetic crosses to
b-actin-tTS, CaMKII-tTS, and ePet-Cremice, and by administration of doxycy-
cline to tTS lines. All animal care and testing was approved by the Institutional
Animal Use and Care Committee and was in accordance with the NIH’s Guide
for the Care and Use of Laboratory Animals.
Tissue
For receptor binding and in situ hybridization analysis, mice were sacrificed by
cervical dislocation and decapitation. 125I-cyanopindolol autoradiography for
5-HT1BR localization was performed based on a previously described proto-
col (Saudou et al., 1994). In situ hybridization was performed based on the
Allen Brain Atlas Protocol using a digoxigenin (DIG)-labeled htr1b cRNA probe
previously described (Tanaka et al., 2012).
Behavior
Aggression assays were conducted on male mice at 13–15 weeks of age, us-
ing a paired housing procedure in which two mice of the same genotype are
co-housed separated by a plexiglas divider, as previously described (Yu
et al., 2014). Operant conditioning studies beginning at 12 weeks of age
were conducted in eight identical operant chambers (Med Associates) on
food-restricted mice. Following behavioral shaping, DRL and Go/No-Go para-
digms were used to test impulsive action.
In Vivo Microdialysis
Samples were collected from the dorsal striatum and nucleus accumbens
brain regions of awake and freely moving mice, at baseline conditions and
following injection of GBR 12090 or escitalopram. Dialysates were analyzed
for DA or 5-HT levels using HPLC.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and eight figures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2015.03.041.
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